photo of

Details

Role Team Leader / Senior Research Officer
Research area Stem Cell Medicine

Contact

Available for student supervision
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. This research led to the discovery that mutations linked to hypertrophic cardiomyopathy increased the number of active myosin motors in mouse and human hearts, providing a mechanism for how these mutations impair contraction, relaxation, and energy utilisation. He received his PhD in Medicine from the University of Sydney in 2017. He then undertook undertake postdoctoral training at the University of Cincinnati, supported by an American Heart Association Postdoctoral Fellowship for this period and continued to focus on the function of MYBPC3, establishing a mechanism for its role in adrenergic signaling in the heart. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, he continues to study molecular mechanisms of genetic heart diseases, now utilising human pluripotent stem cells as a human model of disease. James’ research is currently supported by multiple early career fellowships.
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. ...
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. This research led to the discovery that mutations linked to hypertrophic cardiomyopathy increased the number of active myosin motors in mouse and human hearts, providing a mechanism for how these mutations impair contraction, relaxation, and energy utilisation. He received his PhD in Medicine from the University of Sydney in 2017. He then undertook undertake postdoctoral training at the University of Cincinnati, supported by an American Heart Association Postdoctoral Fellowship for this period and continued to focus on the function of MYBPC3, establishing a mechanism for its role in adrenergic signaling in the heart. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, he continues to study molecular mechanisms of genetic heart diseases, now utilising human pluripotent stem cells as a human model of disease. James’ research is currently supported by multiple early career fellowships.

Top Publications

  • Toepfer, CN, Wakimoto, H, Garfinkel, AC, McDonough, B, Liao, D, Jiang, J, Tai, AC, Gorham, JM, Lunde, IG, Lun, M, et al. Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin. Science Translational Medicine 11(476) : 2019
    view publication
  • McNamara, JW, Sadayappan, S. Skeletal myosin binding protein-C: An increasingly important regulator of striated muscle physiology. Archives of Biochemistry and Biophysics 660: 121 -128 2018
    view publication
  • McNamara, JW, Grimes, KM, Sadayappan, S. Basic Cardiovascular Sciences Scientific Sessions 2018. Circulation Research 123(9) : 1024 -1029 2018
    view publication
  • McNamara, JW, Lynch, TL, Song, T, Rubinstein, JL, Sadayappan, S. Abstract 303: Fast Skeletal Myosin Binding Protein-c Expression in Heart Failure. Circulation Research 123(Suppl_1) : 2018
    view publication
  • Meng, Q, Bhandary, B, Osinska, H, James, J, Shay-Winkler, K, Gulick, J, McNamara, J, Bhuiyan, MS, Sadayappan, S, Robbins, J. Abstract 265: TGF Beta Signaling and Fibrosis in cMyBP-C-dependent Cardiac Disease. Circulation Research 123(Suppl_1) : 2018
    view publication

Page 6 of 8